Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...
Everything touching artificial intelligence (AI) is hot right now, so it's no surprise that the biotech Recursion Pharmaceuticals (RXRX-8.64%) could be positioned to ride the ongoing wave of hype to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results